AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Staples, RJ Segal, BM
Citation: Rj. Staples et Bm. Segal, Triisopropylphosphine sulfide, ACT CRYST E, 57, 2001, pp. O432-O433

Authors: Han, Y Cai, LS Segal, BM
Citation: Y. Han et al., One pot synthesis of 1-chloro-2-chlorocarboxy-4H-quinolizin-4-one and its derivatives, SYN COMMUN, 30(21), 2000, pp. 3985-3995

Authors: Segal, BM Cross, AH
Citation: Bm. Segal et Ah. Cross, Fas(t) track to apoptosis in MS - TNF receptors may suppress or potentiateCNS demyelination, NEUROLOGY, 55(7), 2000, pp. 906-907

Authors: Segal, BM Chang, JT Shevach, EM
Citation: Bm. Segal et al., CPG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo, J IMMUNOL, 164(11), 2000, pp. 5683-5688

Authors: Chang, JT Segal, BM Shevach, EM
Citation: Jt. Chang et al., Role of costimulation in the induction of the IL-12/PL-12 receptor pathwayand the development of autoimmunity, J IMMUNOL, 164(1), 2000, pp. 100-106

Authors: Zhou, CY Raebiger, JW Segal, BM Holm, RH
Citation: Cy. Zhou et al., The influence of net charge on the redox potentials of Fe4S4 cubane-type clusters in aprotic solvents, INORG CHIM, 300, 2000, pp. 892-902

Authors: Osterloh, F Segal, BM Achim, C Holm, RH
Citation: F. Osterloh et al., Reduced mono-, di-, and tetracubane-type clusters containing the [MoFe3S4](2+) core stabilized by tertiary phosphine ligation, INORG CHEM, 39(5), 2000, pp. 980-989

Authors: Nivorozhkin, AL Segal, BM Musgrave, KB Kates, SA Hedman, B Hodgson, KO Holm, RH
Citation: Al. Nivorozhkin et al., Metallocyclopeptide complexes with M-II(S center dot Cys)(4) chromophores, INORG CHEM, 39(11), 2000, pp. 2306-2313

Authors: Chang, JT Segal, BM Nakanishi, K Okamura, H Shevach, EM
Citation: Jt. Chang et al., The costimulatory effect of IL-18 on the induction of antigen-specific IFN-gamma production by resting T cells is IL-12 dependent and is mediated by up-regulation of the IL-12 receptor beta 2 subunit, EUR J IMMUN, 30(4), 2000, pp. 1113-1119

Authors: Shevach, EM Chang, JT Segal, BM
Citation: Em. Shevach et al., The critical role of IL-12 and the IL-12R beta 2 subunit in the generationof pathogenic autoreactive Th1 cells, SPR SEM IMM, 21(3), 1999, pp. 249-262

Authors: Ren, SM Cai, LS Segal, BM
Citation: Sm. Ren et al., Synthesis and characterization of monodeoxynucleotide tethered platinum-(II) and -(IV) complexes, J CHEM S DA, (9), 1999, pp. 1413-1422

Authors: Chang, JT Shevach, EM Segal, BM
Citation: Jt. Chang et al., Regulation of interleukin (IL)-12 receptor beta 2 subunit expression by endogenous IL-12: A critical step in the differentiation of pathogenic autoreactive T cells, J EXP MED, 189(6), 1999, pp. 969-978

Authors: Segal, BM
Citation: Bm. Segal, The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE, RES IMMUNOL, 149(9), 1998, pp. 811-820

Authors: Begolka, WS Miller, SD Segal, BM Racke, MK Lovett-Racke, AE
Citation: Ws. Begolka et al., Antigen-driven regulation of experimental autoimmune encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 842-843

Authors: Segal, BM Willenborg, DO Racke, MK Lovett-Racke, AE Hoffman, LM Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., Immune cell entry to the CNS - a focus for immunoregulation of EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 844-846

Authors: Owens, T Segal, BM Racke, MK Lovett-Racke, AE Begolka, WS Miller, SD
Citation: T. Owens et al., Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Discussion, RES IMMUNOL, 149(9), 1998, pp. 849-850

Authors: Segal, BM Owens, T Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein - Discussion, RES IMMUNOL, 149(9), 1998, pp. 852-854

Authors: Willenborg, DO Owens, T Segal, BM Begolka, WS Miller, SD
Citation: Do. Willenborg et al., T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification - Discussion, RES IMMUNOL, 149(9), 1998, pp. 854-855
Risultati: 1-18 |